CLINICAL_TRIALS
trial_result
· 2018-01-23
Clinical Trial Update: Long Term Efficacy, Safety and Immunogenicity of Enerceptan in Rheumatoid Arthritis ( GEMENE002 ) [Phase 3]
Summary
Phase 3 clinical trial update on Enerceptan for rheumatoid arthritis, focusing on long-term efficacy, safety, and immunogenicity.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gema Biotech S.A. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: UNKNOWN